Jason Hart, Jr.

Biochemistry and Microbiology Student at the University of Maine | 2026 Mayo Summer Undergraduate Research Fellow | 2025 UC Berkeley Amgen Scholar

Orono, Maine, United States

About

Experience

  • Mayo SURF, Mohni Lab at Mayo Clinic Graduate School of Biomedical Sciences
    May 2026 - Present · 3 mos

  • University of Maine (Orono, Maine, United States · On-site)
    • Student Instructor Aid, Phage Genomics
      Sep 2024 - Present · 1 yr 11 mos

      In this position I taught students about Bacteriophage biology in the lab, classroom, and in "Phage Enrichment" office hours. My main responsibilities in the fall semester were maintaining the lab environment, guiding students with several procedures involving characterization of mycobacteriophage, and helping students troubleshoot augmented reality exercises. In the spring semester, I primarily provided feedback to students about making functional annotation calls on viral genes based on bioinformatics tools as well as facilitated cooperation between students in making poster presentations and genome announcements for their novel phages. In "Phage Enrichment" office hours, I offered additional support to students for Phage Genomics, Cell and Molecular Biology, General Chemistry, Organic Chemistry, Calculus, and the Honors Civ Sequence.

    • Undergraduate Research Assistant, King Lab
      Sep 2023 - Present · 2 yrs 11 mos

      I have worked on several projects in the lab, but I use a combination of bioinformatics, large RNA sequencing datasets, and qPCR on Zebrafish models using influenza as a model pathogen to understand how neutrophil regulation in response to infection. My current project has been focused on trying to understand how low dosage arsenic exposure impacts inflammatory signaling.

  • Amgen Scholar, Glaunsinger Lab at University of California, Berkeley
    Jun 2025 - Aug 2025 · 3 mos

    In this 10 week program I took on a project trying to identify possible therapeutics that would interfere with a transcription of late lytic KSHV genes because of the reliance upon virus-specific transcriptional activators. This project ended up morphing into trying to understand the mechanism as to how a class of these potential therapeutics (histone deacetylase inhibitors) interferes with the viral lifecycle.